I. Okamoto et al. / Tetrahedron 68 (2012) 5346e5355
5353
4.12. N-(2,5-Dihydroxyphenyl)-2,2,N-triphenylacetamide (5d)
Mp 100.5e101.5 ꢀC. nmax (KBr) 1636, 1501, 1366 cmꢁ1 1H NMR
4.17. 2,3,4,5,6-Pentafluoro-N-(3,6-dioxocyclohexa-1,4-dien-1-
yl)-N-phenylbenzamide (6c)
;
(300 MHz, DMSO-d6) 9.57 (E1H, s), 9.02 (Z1H, s), 8.79 (E1H, s),
d
Mp 128.0e129.0 ꢀC; nmax (KBr) 1692, 1668 cmꢁ1 1H NMR
;
8.78 (Z1H, s), 7.41e7.09 (15H, m), 6.87 (E1H, d, J¼8.8 Hz), 6.63 (1H,
(300 MHz, CDCl3)
d
7.34 (3H, m), 7.30 (2H, d, J¼9.6 Hz), 6.92 (1H, d,
dd, J¼8.8, 2.9 Hz), 6.53 (Z2H, m), 6.10 (1H, d, J¼2.9 Hz), 5.10 (E1H, s),
J¼10.3 Hz), 6.80 (1H, dd, J¼10.3, 2.4 Hz), 6.52 (1H, d, J¼2.5 Hz); 13C
13
5.08 (Z1H, s); C NMR (75 MHz, DMSO-d6, 120 ꢀC)
d
170.7, 149.6,
NMR (75 MHz, CDCl3) d 186.5, 180.4, 158.8, 147.1, 139.2, 136.4, 136.3,
145.3, 142.6, 139.4, 129.6, 128.1, 127.8, 127.2, 126.0, 125.8, 125.3,
116.7, 116.0, 115.6, 53.9; m/z (EI) 395; HRMS (EI): Mþ, found
395.1528. C26H21NO3 requires 395.1521.
130.7, 130.1, 129.6, 127.5; m/z (EI) 303; HRMS (EI): Mþ, found
393.0423. C19H8NO3F5 requires 393.0424.
4.18. N-(3,6-Dioxocyclohexa-1,4-dien-1-yl)-2,2,N-
triphenylacetamide (6d)
4.13. N-(2,5-Dihydroxyphenyl)-2-(2,4-dinitrophenyl)-N-
phenylacetamide (5e)
Mp 145.0e148.0 ꢀC; nmax (KBr) 1663, 1491, 1379 cmꢁ1
;
1H NMR
(300 MHz, CD2Cl2) 7.44e7.18 (13H, m), 7.15e7.08 (2H, m), 6.86
d
Mp 153.0 ꢀC. nmax (KBr) 1649, 1535, 1348 cmꢁ1
;
1H NMR
(1H, d, J¼10.1 Hz), 6.71 (1H, dd, J¼10.2, 2.5 Hz), 6.36 (1H, d,
(300 MHz, DMSO-d6) 9.55 (Z1H, s), 9.02 (Z1H, s), 8.85 (E2H, s),
d
J¼2.6 Hz), 5.05 (1H, s); 13C NMR (75 MHz, CDCl3)
d 186.8, 181.3,
8.73 (1H, d, J¼2.6 Hz), 8.46 (1H, dd, J¼8.4, 2.6 Hz), 7.77 (1H, d,
J¼8.43 Hz), 7.70e7.08 (5H, m), 6.98e6.43 (3H, m), 4.20 (E1H, d,
J¼17.2 Hz), 4.11 (Z2H, s), 3.99 (E1H, d, J¼16.9 Hz); 13C NMR (75 MHz,
172.8, 149.1, 140.3, 138.6, 136.5, 136.2, 130.1, 130.0, 129.2, 129.0,
128.7, 128.5, 127.3, 55.2; m/z (EI) 393; HRMS (EI): Mþ, found
393.1369. C26H19NO3 requires 393.1365.
CD3OD)
d 171.5, 152.2, 150.5, 148.6, 147.8, 143.9, 139.5, 136.3, 130.9,
129.9, 128.2, 127.7, 127.5, 121.2, 118.7, 118.2, 117.0, 41.1; m/z (EI) 409;
4.19. N-(3,6-Dioxocyclohexa-1,4-dien-1-yl)-2-(2,4-
dinitrophenyl)-N-phenylacetamide (6e)
HRMS (EI): Mþ, found 409.0906. C20H15N3O7 requires 409.0910.
4.14. N-(2,5-Dihydroxyphenyl)-2-(pentafluorophenyl)-N-
phenylacetamide (5f)
Mp 85.0e87.0 ꢀC; nmax (KBr) 1668, 1535, 1348 cmꢁ1
(300 MHz, CDCl3)
;
1H NMR
d
8.93 (1H, d, J¼2.2 Hz), 8.42 (1H, dd, J¼8.4,
2.2 Hz), 7.60 (1H, d, J¼8.4 Hz), 7.58e7.42 (5H, m), 6.85 (1H, d,
Mp 167.5e169.0 ꢀC. nmax (KBr) 1670, 1523, 1508, 1352, 1230,
J¼10.3 Hz), 6.74 (1H, dd, J¼10.3, 2.2 Hz), 6.52 (1H, d, J¼2.2 Hz), 4.11
1128 cmꢁ1
;
1H NMR (300 MHz, CD3OD)
d
7.66e7.15 (5H, m), 6.85
(2H, s); 13C NMR (75 MHz, CDCl3)
d 186.7, 181.2, 168.8, 148.8, 148.0,
(1H, d, J¼8.8 Hz), 6.71 (1H, dd, J¼8.8, 2.6 Hz), 6.64 (1H, d, J¼2.9 Hz),
147.4, 140.0, 136.8, 136.4, 136.3, 134.8, 130.648, 130.591, 129.7, 128.4,
127.3, 120.6, 40.4; m/z (EI) 407; HRMS (EI): Mþ, found 407.0769.
C20H13N3O7 requires 407.0753.
3.90 (1H, d, J¼16.9 Hz), 3.78 (1H, d, J¼16.1 Hz); 13C NMR (75 MHz,
DMSO-d6, 120 ꢀC)
d 166.3, 150.0, 145.5, 142.2, 128.9, 127.9, 125.5,
125.3, 117.2, 116.1, 115.3, 28.1; m/z (EI) 409; HRMS (EI): Mþ, found
409.0753. C20H12NO3F5 requires 409.0737.
4.20. N-(3,6-Dioxocyclohexa-1,4-dien-1-yl)-2-
(pentafluorophenyl)-N-phenylacetamide (6f)
4.15. N-(3,6-Dioxocyclohexa-1,4-dien-1-yl)-N-
phenylbenzamide (6a)
Mp 149.0e151.0 ꢀC; nmax (KBr) 3055, 1701, 1655, 1599, 1529,
1508, 1254, 1124 cmꢁ1 1H NMR (300 MHz, CDCl3)
; d 7.51 (3H, m),
7.39 (2H, m), 6.87 (1H, d, J¼10.3 Hz), 6.74 (1H, dd, J¼10.3, 2.6 Hz),
A solution of 5a (40 mg, 0.16 mmol), 0.1 mL of 2 M hydrochloric
acid, and iron (III) chloride (77.8 mg, 0.48 mmol) in 20 mL of
methanol was stirred at ambient temperature for 1 h, then poured
into water. The aqueous mixture was extracted with ethyl acetate.
The organic layer was dried over magnesium sulfate, the solvent
was removed under reduced pressure, and the residue was flash-
chromatographed (AcOEt/n-hexane 1:2) to afford 27 mg (70%) of
amide 6a. Mp 145e149 ꢀC; Anal. Found: C, 69.48; H, 4.90; N, 5.87.
C14H11NO3 requires C, 69.70; H, 4.60; N, 5.81%; nmax (KBr) 1684,
6.45 (1H, d, J¼2.6 Hz), 3.67 (2H, s); 13C NMR (75 MHz, CD2Cl2)
d
186.7, 181.0, 167.8, 148.0, 140.0, 136.2, 136.1, 130.4, 130.3, 129.3,
128.1, 28.5; m/z (EI) 407; HRMS (EI): Mþ, found 407.0570.
C20H10NO3F5 requires 407.0581.
4.21. Single-crystal X-ray crystallography
New crystallographic data were collected on a CCD diffractom-
ꢀ
eter with Mo K
a
(l
¼0.71073 A) radiation. Data collections for al-
1654 cmꢁ1; 1H NMR (300 MHz, CDCl3)
d 7.44 (3H, m), 7.27 (2H, m),
most compounds were carried out at room temperature or low
temperature (90e273 K) using liquid nitrogen. For crystal of 6b,
which is very thin plate, a data collection was carried out at 15 K
using liquid helium. All of the crystal structures were solved by
direct methods with SHELXS-97 and refined with full-matrix least-
squares SHELXL-97.44 All non-hydrogen atoms were refined an-
isotropically. Hydrogen atoms of the amides were included at their
calculated positions. Crystallographic data are summarized below
(for published data, only CCDC deposit numbers are given).25
Compound 4a: CCDC-635794.
6.88 (1H, d, J¼10.3 Hz), 6.74 (1H, dd, J¼10.3 Hz), 6.37 (1H, d,
J¼2.4 Hz), 2.06 (3H, s); 13C NMR (75 MHz, CDCl3)
d 187.0, 181.4,
171.2, 149.1, 141.1, 136.5, 136.2, 130.2, 129.8, 129.0, 128.0, 22.7; m/z
(EI) 241.
Compounds 6bef were prepared in the same manner as de-
scribed for 6a.
4.16. N-(3,6-Dioxocyclohexa-1,4-dien-1-yl)-N-
phenylbenzamide (6b)
Compound 4b: recrystallized from AcOEt/n-hexane. C21H19NO3,
Mp 131.0e133.0 ꢀC; nmax (KBr) 1684, 1655 cmꢁ1
;
1H NMR
Mr¼333.37, triclinic, Pꢁ1, a¼9.584(1), b¼11.199(1), c¼18.362(2) A,
ꢀ
3
ꢀ
ꢀ
(300 MHz, CDCl3) 7.60 (2H, m), 7.31 (6H, m), 7.08 (2H, m), 6.86
d
a
¼101.791(2),
b
¼96.568(2),
g
¼109.903(2) , V¼1777.4(4) A , Z¼4,
(1H, d, J¼9.7 Hz), 6.75 (1H, dd, J¼10.3, 2.6 Hz), 6.22 (1H, d,
Dcalcd¼1.246 Mg mꢁ3, 2qmax¼54.96ꢀ, T¼273 K, 10,547 reflections
J¼2.4 Hz); 13C NMR (75 MHz, CD2Cl2)
d
187.2, 182.1, 171.3, 150.9,
measured, 6855 unique (Rint¼0.026),
m
¼0.083 mme1. The final R1
142.3, 137.0, 136.4, 134.8, 132.0, 130.2, 129.9, 128.6, 128.1, 128.0,
127.5; m/z (EI) 303; HRMS (EI): Mþ, found 303.0927. C19H13NO3
requires 303.0895.
and wR2 were 0.0479 and 0.0732 (I>2s(I)). CCDC-869639.
Compound 4c: recrystallized from AcOEt/n-hexane. C21H14F5NO3,
Mr¼423.33, monoclinic, P21/c, a¼9.0044(12), b¼10.9394(14),